Sudeep Pharma IPO
Sudeep Pharma IPO is listed on BSE and NSE, priced at ₹563–₹593 per share. The stock debuted at ₹730, delivering a listing gain of 23.1%. The IPO had a lot size of ₹25 shares and a minimum investment of ₹14,825.
Sudeep Pharma Limited IPO
- IPO Dates
- Nov 21, 2025 – Nov 25, 2025
- Price band
- ₹563-593 per equity share
- Minimum Investment
- ₹14,825
- Issue size
- ₹895 Cr
- Lot size
- 25
- Allotment Date
- Nov 26, 2025
- Listing
- Nov 28, 2025
- Listing At
- BSE, NSE
IPO timeline
-
Nov 21, 2025
Open Date
Completed
-
Nov 25, 2025
Close Date
Completed
-
Nov 26, 2025
Allotment Date
Completed
-
Nov 28, 2025
Listing Date
Completed
Price Summary
- Last closing
- 741.00 (24.96%)
- 52 week high
- 816.35
- 52 week low
- 524.05
- Last update
Sudeep Pharma IPO Subscription Details
View Subscription DetailsSudeep Pharma IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Sudeep Pharma IPO Essentials
Sudeep Pharma IPO Details
Sudeep Pharma IPO is priced at ₹563-593 per share with a total issue size of 895 crore. The IPO has a lot size of 25 shares and is listed on BSE and NSE.
- Issue price
- ₹563-593 per equity share
- Lot size
- 25 shares
- Face value
- ₹1 Per Equity Share
- Issue size
- Total 895.00 Cr :
#Fresh Issue : 16,02,024 shares(aggregating up to ₹95.00 Cr) +
#OFS : 1,34,90,726 shares of ₹1(aggregating up to ₹800.00 Cr) - Total issue size
- 1,50,92,750 shares
(aggregating up to ₹895 crore) - Fresh issue
- 16,02,024 shares
(aggregating up to ₹95 crore) - Offer for sale (OFS)
- 1,34,90,726 shares
(aggregating up to ₹800 crore) - Listing at
- BSE, NSE
- List price
- 730.0(NSE)
- Listing date
- Registrar
- MUFG Intime India Pvt Ltd
- Lead manager
-
ICICI Securities Ltd., IIFL Capital Services Ltd.
Market Lot Size
Investors can bid for a minimum of 25 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 25 | ₹14,825 |
| Retail(max) | 13 | 325 | ₹1,92,725 |
| sHNI(min) | 14 | 350 | ₹2,07,550 |
| sHNI(max) | 67 | 1,675 | ₹9,93,275 |
| sHNI(min) | 68 | 1,700 | ₹10,08,100 |
Sudeep Pharma IPO Reservation
Sudeep Pharma IPO reservation details show category-wise allocation of shares. Out of the total 15092750 shares, approximately 20% are reserved for QIB, 15% for NII, 35% for retail investors, and 30% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 4527823 (30%) | |
| QIB Shares Offered | 3018553 (20%) | |
| NII (HNI) Shares Offered | 2263912 (15%) | |
| bHNI > ₹10L | 1509275 (10%) | 4312 |
| sHNI < ₹10L | 754637 (5%) | 2156 |
| Retail Shares Offered | 5282462 (35%) | 211298 |
| Total Shares Offered | 15092750 (100%) |
Sudeep Pharma IPO Analytics
Sudeep Pharma IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Sudeep Pharma IPO Subscription Status
Sudeep Pharma IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO is currently subscribed 93.71x, indicating strong demand across investor categories.
| As on | QIB |
NII
bHNI
sHNI
|
Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 30,18,553 |
22,63,912
15,09,275
7,54,637
|
52,82,462 | 1,05,64,927 |
|
Day 1
21-11-25 05:00 PM
|
0.09 x |
3.00x
2.75x
3.51x
|
1.51 x | 1.42 x |
|
Day 2
24-11-25 05:00 PM
|
0.13 x |
12.01x
10.99x
14.04x
|
4.99 x | 5.11 x |
|
Day 3
25-11-25 05:00 PM
|
213.08 x |
116.72x
134.91x
80.33x
|
15.65 x | 93.71 x |
|
Total No. of Applications
|
bHNI | sHNI | Retail |
|---|---|---|---|
| 3022167 (Approx) | 27.29x | 76.34x | 12.88x |
Sudeep Pharma Valuations
Earnings
- EPS Pre IPO
- ₹12.46/-
- EPS Post IPO
- ₹11.07/-
- P/E Pre IPO
- 47.61
- P/E Post IPO
- 53.55
Returns
- RoNW
- 27.88%
- PAT Margin
- 27.63%
Fundamentals
- Debt / Equity
- 0.20
- Price / Book
- 12.93
- Market Cap
- 6697.85 Cr.
Sudeep Pharma Financials( In Crs.)
| 30-Jun-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|---|
| Assets | 922.26 | 717.17 | 513.87 | 420.11 |
| Revenue | 130.08 | 511.33 | 465.38 | 438.26 |
| Profit After Tax | 31.27 | 138.69 | 133.15 | 62.32 |
| Net Worth | 688.32 | 497.53 | 359.07 | 226.29 |
| Reserves & Surplus | 668.52 | 481.11 | 354.59 | 221.88 |
| Total Borrowing | 135.97 | 135.25 | 75.03 | 82.26 |
Sudeep Pharma Company & Offer Insights
About Sudeep Pharma
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.It has six manufacturing facilities that have a combined production capacity of 50,000 MT, manufacturing minerals such as calcium, iron, magnesium, zinc, potassium, and sodium.
The company supplies over 200 products to a wide customer base across the pharma, food, and nutrition sectors.The company has strong R&D capabilities comprising in-house labs and pilot-scale facilities for mineral salts and excipients.
Product Portfolio:
Pharmaceutical, Food and Nutrition Business
Specialty Ingredients Business
Triturates As of 31 December 2024, the company had 704 permanent employees.
Sudeep Pharma Promoter(s)
Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani HUF, Riva Resources Private Limited, and Bhayani Family Trust are the company's promoters of Sudeep Pharma.
Sudeep Pharma IPO Issue Objectives
- •
- Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I– ₹75.81 Cr
- •
- General corporate purposes
Sudeep Pharma IPO - Anchor Investors
Sudeep Pharma raises over Rs 268 crore via anchor book.
Among anchor investors who participated in the IPO anchor book of Sudeep Pharma were SBI Mutual Fund, HDFC AMC, ICICI Prudential MF, Axis Mutual Fund, WhiteOak Capital, Aditya Birla Sun Life AMC, Quant MF, SBI Life Insuance, Bandhan MF, Tata AIA Life Insurance, and Edelweiss.
Sudeep Pharma IPO - Strengths and Risks
Sudeep Pharma IPO strengths and risks highlight key business factors, financial position, and market sentiment that may impact investor interest.
Strengths
Risks
Contact Information
Contact Details
Sudeep Pharma
+91 265 284 0656
129/1/A, GIDC Estate, Nandesari, Vadodara, Gujarat, 391340
Registrar Contact Details
Frequently Asked Questions
Click any question to reveal the answer
Sudeep Pharma IPO is a book-built IPO worth ₹895 crore. The price band is ₹563–₹593 per share. The IPO opens on Nov 21, 2025 and closes on Nov 25, 2025. It will be listed on BSE and NSE. MUFG Intime India Pvt Ltd is the registrar.
The price band of Sudeep Pharma IPO is ₹563 to ₹593 per share.
The lot size of Sudeep Pharma IPO is 25 shares.
The minimum investment for Sudeep Pharma IPO is approximately ₹14,825 based on the upper price band .
Sudeep Pharma IPO opens on Nov 21, 2025 and closes on Nov 25, 2025.
The allotment date of Sudeep Pharma IPO is Nov 26, 2025.
Sudeep Pharma IPO is expected to be listed on Nov 28, 2025, on BSE and NSE .
Sudeep Pharma IPO listed on Nov 28, 2025. It was issued at ₹730.0(NSE) and is currently around ₹741.00 as on 9-Jun-2026 3:30 PM, which is approximately 25.0% versus issue price. The 52-week high is ₹816.35.
Based on listing and post-listing performance, Sudeep Pharma IPO delivered around 25.0% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.
To buy Sudeep Pharma IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.
Sudeep Pharma IPO valuation snapshot: P/E 53.55, EPS ₹11.07/-, P/B 12.93, RoNW 27.88%, and market cap 6697.85 Cr.
To apply for Sudeep Pharma IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Sudeep Pharma IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Sudeep Pharma IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Sudeep Pharma IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Sudeep Pharma IPO allotment status on IPO Ji for quick and easy access.